LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
WEYS
Weyco Group, Inc.
WEYS has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
WEYS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
WEYS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
WEYS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.6x | $35.65 | -40% |
| Fair | 11x | $45.12 | -25% |
| Expensive | 14x | $59.32 | -0.8% |
| Current | 14x | $59.77 | — |
Historical ranges are pointers, not guarantees.
WEYS's PE is in its expensive range at 14x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
WEYS Forward outlook
There aren't enough analyst estimates for WEYS to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
WEYS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $4.13 | +63% |
| Q2 2026 | $3.63 | +35% |
| Q1 2026 | $2.48 | -18% |
| Q4 2025 | $2.41 | -24% |
| Q3 2025 | $2.54 | -16% |
| Q2 2025 | $2.69 | -15% |
| Q1 2025 | $3.04 | -1.3% |
| Q4 2024 | $3.16 | -0.3% |
WEYS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over WEYS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
WEYS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $77M | +5.3% |
| Q2 2026 | $62.2M | +6.9% |
| Q1 2026 | $68M | 0% |
| Q4 2025 | $76.8M | -4.6% |
| Q3 2025 | $73.1M | -1.6% |
| Q2 2025 | $58.2M | -8.9% |
| Q1 2025 | $68M | -4.9% |
| Q4 2024 | $80.5M | -0.1% |
WEYS's revenue is recovering but still below its 2021 peak: $77M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +6.8 points |
| Q2 2026 | 27% | +21 points |
| Q1 2026 | 11% | +0.7 points |
| Q4 2025 | 13% | -1.1 points |
| Q3 2025 | 11% | -2.7 points |
| Q2 2025 | 6.7% | -3.7 points |
| Q1 2025 | 10% | -1.2 points |
| Q4 2024 | 14% | +0.1 points |
WEYS has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
WEYS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $990K | +$2.3M |
| Q2 2026 | $6.8M | -32% |
| Q1 2026 | $16.9M | +355% |
| Q4 2025 | $23.1M | +16% |
| Q3 2025 | -$1.3M | -$393K |
| Q2 2025 | $10M | +216% |
| Q1 2025 | $3.7M | -74% |
| Q4 2024 | $19.9M | -43% |
WEYS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
WEYS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +90K shares |
| 1 year | +1.2% | +116K shares |
| 3 years | +1.3% | +121K shares |
| 5 years | -1.1% | -106K shares |
| Available history | -3% | -302K shares |
WEYS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $34,000 |
| Q4 2025 | $1.2M |
| Q3 2025 | $930,000 |
| Q2 2025 | $2.4M |
| Q1 2025 | $732,000 |
| Q4 2024 | $19,000 |
WEYS spent $1M buying back its own shares over the past year, down 70% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
WEYS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.7x | Net Cash |
| Q4 2025 | -3.0x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
WEYS has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
WEYS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 81.4 | Overbought |
| Stochastic | 76.8 | Neutral |
WEYS's weekly RSI is 81 (overbought) and its Stochastic is 77 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
WEYS PE vs Consumer Cyclical Sector
| Metric | WEYS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 20% below |
| PE % | 84 | 47 | 37 pts above |
WEYS is trading at 14x earnings, a 20% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
WEYS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $53.2 | 12% above |
| 20 week MA | $46.8 | 28% above |
| 50 week MA | $38.6 | 55% above |
| 100 week MA | $35.1 | 70% above |
| 200 week MA | $32.4 | 85% above |
WEYS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
WEYS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.6 | $16.3 | -39% |
| 2021 | $16.3 | $22.8 | +39% |
| 2022 | $22.8 | $24.4 | +7% |
| 2023 | $24.4 | $31.4 | +29% |
| 2024 | $31.4 | $37.2 | +19% |
| 2025 | $37.2 | $31.3 | -16% |
| 2026 YTD | $31.3 | $59.8 | +91% |
WEYS has the edge over LCID on returns for 2026, with the stronger performance.